Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 38
1998 115
1999 171
2000 175
2001 166
2002 172
2003 173
2004 197
2005 205
2006 249
2007 239
2008 224
2009 254
2010 293
2011 414
2012 467
2013 442
2014 424
2015 468
2016 436
2017 428
2018 399
2019 121
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

5,611 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
Kim SM and Song IH. Korean J Intern Med 2018 - Review. PMID 29961309 Free PMC article.
Hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is associated with increased liver-related morbidity and mortality rates, accelerated progression to end-stage renal disease, and risk of cardiovascular events. ...These positive results have revolutionized the treatment of chronic HCV infection in this population. In this review, we address the impact of chronic HCV infection in CKD patients, and discuss their management using next-generation DAAs....
Hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is associated with increased liver-related morbidity
Treatment of early stage chronic hepatitis C virus infection.
Ponziani FR, et al. Expert Rev Clin Pharmacol 2018 - Review. PMID 29498556
Treatment of Hepatitis C Virus (HCV) with direct acting antivirals (DAAs) is able to achieve the cure of infection in almost the totality of patients, independently of the characteristics of the individual and the virus, using short treatment schedules, and without the need of ribavirin. ...Areas covered: This review evaluates the aspects underlying the benefit of treating chronic HCV infection at the early stage of disease. ...
Treatment of Hepatitis C Virus (HCV) with direct acting antivirals (DAAs) is able to achieve the cure of infection in almost t …
[Selection of direct-acting antiviral agents for chronic hepatitis C infection].
He YJ, et al. Zhonghua Gan Zang Bing Za Zhi 2018 - Review. PMID 29804388 Chinese.
The elimination of hepatitis C virus(HCV) infection is still a long way to go. Direct-acting antiviral agents (DAAs) can make HCV completely cured by targeting various stages of its replication life cycle and meanwhile standardize and simplify the treatment. ...
The elimination of hepatitis C virus(HCV) infection is still a long way to go. Direct-acting antiviral agents (DAAs) can make …
Direct-acting antiviral drugs for chronic hepatitis C and risk of major vascular events: a systematic review.
Tamborini Permunian E, et al. Intern Emerg Med 2018 - Review. PMID 29611106
Direct-acting antiviral drugs (DAAs) were recently approved for treating hepatitis C virus-related chronic hepatitis. As advanced chronic liver disease may predispose patients to thrombotic events, it is still uncertain whether DAAs may influence the actual risk of major arterial and venous thrombotic events. We performed a systematic review to assess the incidence of major vascular events in patients receiving DAAs for HCV chronic hepatitis during phase-III randomized controlled trials (RCTs). ...
Direct-acting antiviral drugs (DAAs) were recently approved for treating hepatitis C virus-related chronic hepatitis
The impact of liver steatosis on early and sustained treatment response in chronic hepatitis C patients.
Găman AE, et al. Rom J Morphol Embryol 2017. PMID 28523305 Free article.
Steatosis is a frequent feature of hepatitis C virus (HCV) infection. Steatosis may be an important cofactor in both accelerating fibrosis and increasing liver necroinflammatory activity in chronic hepatitis C. ...There were selected to take part to the research 210 patients with chronic hepatitis C who have fulfilled all inclusion and exclusion criteria and were treated with PEG-IFN plus Ribavirin. ...
Steatosis is a frequent feature of hepatitis C virus (HCV) infection. Steatosis may be an important cofactor in both accelerat …
[Hepatitis C].
Weiß J and Geier A. MMW Fortschr Med 2015 - Review. PMID 26953483 German.
Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
Economides MP, et al. Cancer 2018. PMID 29149493 Free PMC article.
BACKGROUND: Although an association between hepatitis C virus (HCV) infection and oropharyngeal cancers (OPCs) has been reported, to the authors' knowledge the clinical significance of this epidemiological finding remains unknown. ...
BACKGROUND: Although an association between hepatitis C virus (HCV) infection and oropharyngeal cancers (OPCs) has been report …
Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes.
Shah SR, et al. Indian J Gastroenterol 2016. PMID 27844277
BACKGROUND AND AIMS: Although chronic hepatitis C virus (HCV) infection affects millions of people in India, few studies have assessed host, viral, and disease characteristics of chronically infected patients at national and regional levels. Such information is critical to support large scale screening and treatment initiatives for chronic HCV infection in India. METHODS: Patients with known chronic HCV infection making routine or for-cause visits to the participating study centers were enrolled in this observational study. ...
BACKGROUND AND AIMS: Although chronic hepatitis C virus (HCV) infection affects millions of people in India, few studie …
5,611 results
Jump to page
Feedback